Financial Engines Advisors L.L.C. cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 37.5% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 2,398 shares of the healthcare conglomerate's stock after selling 1,437 shares during the period. Financial Engines Advisors L.L.C.'s holdings in UnitedHealth Group were worth $1,256,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. WP Advisors LLC raised its position in shares of UnitedHealth Group by 9.4% in the 1st quarter. WP Advisors LLC now owns 5,095 shares of the healthcare conglomerate's stock valued at $2,669,000 after purchasing an additional 438 shares in the last quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors raised its position in shares of UnitedHealth Group by 3.4% during the 1st quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors now owns 4,102 shares of the healthcare conglomerate's stock valued at $2,146,000 after acquiring an additional 133 shares in the last quarter. Ballast Inc. raised its position in shares of UnitedHealth Group by 1.5% during the 1st quarter. Ballast Inc. now owns 14,462 shares of the healthcare conglomerate's stock valued at $7,574,000 after acquiring an additional 207 shares in the last quarter. Maia Wealth LLC raised its position in shares of UnitedHealth Group by 10.7% during the 1st quarter. Maia Wealth LLC now owns 3,928 shares of the healthcare conglomerate's stock valued at $2,057,000 after acquiring an additional 380 shares in the last quarter. Finally, SouthState Corp raised its position in shares of UnitedHealth Group by 3.3% during the 1st quarter. SouthState Corp now owns 9,019 shares of the healthcare conglomerate's stock valued at $4,724,000 after acquiring an additional 288 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.
UnitedHealth Group Stock Up 3.7%
NYSE UNH traded up $9.22 during trading on Tuesday, hitting $261.59. 12,160,581 shares of the company traded hands, compared to its average volume of 18,478,328. The company has a market capitalization of $237.30 billion, a P/E ratio of 11.33, a PEG ratio of 1.63 and a beta of 0.43. The business has a fifty day simple moving average of $289.94 and a 200 day simple moving average of $402.24. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The business's revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the company posted $6.80 EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.4%. The ex-dividend date was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is currently 38.30%.
Wall Street Analyst Weigh In
UNH has been the topic of several research reports. Piper Sandler dropped their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Oppenheimer lowered their price objective on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Wall Street Zen cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Baird R W downgraded UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Finally, Barclays reiterated an "overweight" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $366.52.
Check Out Our Latest Stock Report on UnitedHealth Group
Insider Activity
In related news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO John F. Rex purchased 17,175 shares of the business's stock in a transaction on Friday, May 16th. The stock was purchased at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer owned 203,796 shares in the company, valued at approximately $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock worth $31,607,768 over the last 90 days. Company insiders own 0.28% of the company's stock.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report